This website uses cookies, with the aim of ensuring that you have the best possible online experience. In using our website, you are giving your consent to the terms and conditions of our privacy policy. privacy policy.
closePlease join our webinar on the launch of our new Galileo Biotech Innovation Fund.
The fund offers focused access to companies in the field of genome editing. Representing the next step in the evolution of medical technology, genome editing holds the potential to cure a variety of rare diseases but also offers a novel approach to more common conditions with established treatments. Further applications range from livestock to crop science.
Thursday, March 16th 2021
2PM Zurich
Please contact us for the login details.